| Trial ID: | L3896 |
| Source ID: | NCT04823208
|
| Associated Drug: |
Ly3437943
|
| Title: |
A Study of LY3437943 in Japanese Participants With Type 2 Diabetes Mellitus (T2DM)
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Mellitus, Type 2
|
| Interventions: |
DRUG: LY3437943|DRUG: Placebo
|
| Outcome Measures: |
Primary: Number of Participants with One or More Serious Adverse Event(s) (SAEs) Considered by the Investigator to be Related to Study Drug Administration, A summary of SAEs and other non-serious adverse events (AEs), regardless of causality, will be reported in the Reported Adverse Events module, Baseline through Day 106 | Secondary: Pharmacokinetics (PK): Maximum Concentration (Cmax) of LY3437943, PK: Cmax of LY3437943, Predose on Day 1 through Day 81|PK: Area Under the Concentration Versus Time Curve (AUC) of LY3437943, PK: AUC of LY3437943, Predose on Day 1 through Day 81|Change from Baseline in Mean Daily Plasma Glucose (PG), Change from baseline in mean daily PG from 6-point PG profile, Baseline through Day 80|Change from Baseline in Glycated Hemoglobin (HbA1c), Change from Baseline in HbA1c, Baseline through Day 78|Change from Baseline in Fasting Glucose, Change from Baseline in Fasting Glucose, Baseline through Day 78|Change from Baseline in Body Weight, Change from Baseline in Body Weight, Baseline through Day 78
|
| Sponsor/Collaborators: |
Sponsor: Eli Lilly and Company
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE1
|
| Enrollment: |
64
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: BASIC_SCIENCE
|
| Start Date: |
2021-05-24
|
| Completion Date: |
2022-06-23
|
| Results First Posted: |
|
| Last Update Posted: |
2022-08-22
|
| Locations: |
Medical Corporation Heishinkai OCROM Clinic, Suita-shi, Osaka, 565-0853, Japan|P-one clinic, Hachioji, Tokyo, 192-0071, Japan|Clinical Research Hospital Tokyo, Shinjuku-ku, Tokyo, 162-0053, Japan|Yokohama Minoru Clinic, Yokohama, 232-0064, Japan
|
| URL: |
https://clinicaltrials.gov/show/NCT04823208
|
